Skip to main content
Clinical Trials/NCT03072459
NCT03072459CompletedNot Applicable

A Retrospective Study of the Navio™ Robotic-assisted Surgical System

Smith & Nephew, Inc.5 sites in 1 country128 target enrollmentStarted: July 10, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
128
Locations
5
Primary Endpoint
Evaluate the Navio™ System for Revisions at 2+ Years Post-surgical Implantation Survivorship

Study Overview

Brief Summary

A retrospective, multi-center, cohort study with prospective follow-up and comparison to historical control

Detailed Description

Subjects who had previously received the Navio robotic-assisted surgical system for unilateral knee replacement (UKR) were assessed to determine the 2-year safety and effectiveness of the Navio system.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Male or female subjects ≥ 18 years old (at the time of surgery) who have undergone Navio System-assisted UKR at least 2 years prior to enrollment. This includes UKR procedures with all Unicondylar Knee cemented implant designs.
  • Subject had a primary diagnosis of unicompartmental, non-inflammatory degenerative joint disease including osteoarthritis, traumatic arthritis, or avascular necrosis, required correction of functional deformity, or required treatment of fractures that were unmanageable using other techniques.

Exclusion Criteria

  • Subject received the Navio System-assisted UKR on the index joint as a revision for a previously failed UKR.
  • Subject, in the opinion of the Investigator, had advanced osteoarthritis or joint disease at the time of surgery and was better suited for Total Knee Arthroplasty (TKA).
  • Subject, in the opinion of the Investigator, had a neuromuscular disorder that prohibited control of the index joint.
  • Subject, in the opinion of the Investigator, was morbidly obese.
  • Subject, in the opinion of the Investigator, was contraindicated for UKR.
  • Subject (prospective subjects only), in the opinion of the Investigator, has an emotional or neurological condition including mental illness, mental retardation, drug or alcohol abuse.
  • Subject (prospective subjects only) is a prisoner.

Outcomes

Primary Outcomes

Evaluate the Navio™ System for Revisions at 2+ Years Post-surgical Implantation Survivorship

Time Frame: Preoperative (Baseline) and 24, 48, 72, 96, and 120 weeks postoperatively

Analysis of the absence of device revision (overall survivorship) outcomes assessed from Baseline through 120 weeks post-surgical implantation.

Secondary Outcomes

  • Evaluation of Efficacy Based on Veterans RAND 12 (VR-12) Assessments(Preoperative (Baseline) and 6, 12, 18, 24, 30, and 36 months postoperatively)
  • Postoperative 24-Month Evaluation of Efficacy Based on Radiographic Findings(24 months postoperatively)
  • Postoperative 12-Month Evaluation of Efficacy Based on Radiographic Findings(12 months postoperatively)
  • Postoperative 18-Month Evaluation of Efficacy Based on Radiographic Findings(18 months postoperatively)
  • Preoperative Evaluation of Efficacy Based on Radiographic Findings(Preoperative (Baseline))
  • Postoperative 6-Month Evaluation of Efficacy Based on Radiographic Findings(6 months postoperatively)
  • Evaluation of Efficacy Based on Knee Society Score (KSS) Assessments(Preoperative (Baseline) and 6, 12, 18, 24, 30, and 36 months postoperatively)
  • Postoperative 30-Month Evaluation of Efficacy Based on Radiographic Findings(30 months postoperatively)
  • Postoperative 36-Month Evaluation of Efficacy Based on Radiographic Findings(36 months postoperatively)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (5)

Loading locations...

Similar Trials